Cite
Hallengärd D, Bråve A, Isaguliants M, et al. A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines. Genet Vaccines Ther. 2012;10(1):5doi: 10.1186/1479-0556-10-5.
Hallengärd, D., Bråve, A., Isaguliants, M., Blomberg, P., Enger, J., Stout, R., King, A., & Wahren, B. (2012). A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines. Genetic vaccines and therapy, 10(1), 5. https://doi.org/10.1186/1479-0556-10-5
Hallengärd, David, et al. "A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines." Genetic vaccines and therapy vol. 10,1 (2012): 5. doi: https://doi.org/10.1186/1479-0556-10-5
Hallengärd D, Bråve A, Isaguliants M, Blomberg P, Enger J, Stout R, King A, Wahren B. A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines. Genet Vaccines Ther. 2012 Aug 08;10(1):5. doi: 10.1186/1479-0556-10-5. PMID: 22873174; PMCID: PMC3532290.
Copy
Download .nbib